FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W978756987> ?p ?o ?g. }

• W978756987 endingPage "e0132620" @default.
• W978756987 startingPage "e0132620" @default.
• W978756987 abstract "Hematopoietic stem cell transplantation (HSCT) and consolidation chemotherapy have been used to treat intermediate-risk acute myeloid leukemia (AML) patients in first complete remission (CR1). However, it is still unclear which treatments are most effective for these patients. The aim of our study was to analyze the relapse-free survival (RFS) and overall survival (OS) benefit of allogeneic HSCT (alloHSCT) for intermediate-risk AML patients in CR1. A meta-analysis of prospective trials comparing alloHSCT to non-alloHSCT (autologous HSCT [autoHSCT] and/or chemotherapy) was undertaken. We systematically searched PubMed, Embase, and the Cochrane Library though October 2014, using keywords and relative MeSH or Emtree terms, 'allogeneic'; 'acut*' and 'leukem*/aml/leukaem*/leucem*/leucaem*'; and 'nonlympho*' or 'myelo*'. A total of 7053 articles were accessed. The primary outcomes were RFS and OS, while the secondary outcomes were treatment-related mortality (TRM) and relapse rate (RR). Hazard ratios (HR) and 95% confidence intervals (CI) were calculated for each outcome. The primary outcomes were RFS and OS, while the secondary outcomes were TRM and RR. We included 9 prospective controlled studies including 1950 adult patients. Patients with intermediate-risk AML in CR1 who received either alloHSCT or non-alloHSCT were considered eligible. AlloHSCT was found to be associated with significantly better RFS, OS, and RR than non-alloHSCT (HR, 0.684 [95% CI: 0.48, 0.95]; HR, 0.76 [95% CI: 0.61, 0.95]; and HR, 0.58 [95% CI: 0.45, 0.75], respectively). TRM was significantly higher following alloHSCT than non-alloHSCT (HR, 3.09 [95% CI: 1.38, 6.92]). However, subgroup analysis showed no OS benefit for alloHSCT over autoHSCT (HR, 0.99 [95% CI: 0.70, 1.39]). In conclusion, alloHSCT is associated with more favorable RFS, OS, and RR benefits (but not TRM outcomes) than non-alloHSCT generally, but does not have an OS advantage over autoHSCT specifically, in patients with intermediate-risk AML in CR1." @default.
• W978756987 created "2016-06-24" @default.
• W978756987 creator A5000815865 @default.
• W978756987 creator A5001717980 @default.
• W978756987 creator A5012278873 @default.
• W978756987 creator A5017617692 @default.
• W978756987 creator A5021880262 @default.
• W978756987 creator A5023492006 @default.
• W978756987 creator A5029908033 @default.
• W978756987 creator A5034046400 @default.
• W978756987 creator A5037620398 @default.
• W978756987 creator A5042315486 @default.
• W978756987 creator A5059420555 @default.
• W978756987 creator A5065243448 @default.
• W978756987 creator A5075736599 @default.
• W978756987 creator A5081146412 @default.
• W978756987 creator A5086195538 @default.
• W978756987 creator A5088234024 @default.
• W978756987 creator A5088688923 @default.
• W978756987 date "2015-07-21" @default.
• W978756987 modified "2023-10-10" @default.
• W978756987 title "Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation in Intermediate-Risk Acute Myeloid Leukemia Adult Patients in First Complete Remission: A Meta-Analysis of Prospective Studies" @default.
• W978756987 cites W1492609361 @default.
• W978756987 cites W1586473141 @default.
• W978756987 cites W1629163346 @default.
• W978756987 cites W1675996391 @default.
• W978756987 cites W1704551630 @default.
• W978756987 cites W1709953766 @default.
• W978756987 cites W1835148062 @default.
• W978756987 cites W1883249332 @default.
• W978756987 cites W1902703187 @default.
• W978756987 cites W1964270019 @default.
• W978756987 cites W1970975433 @default.
• W978756987 cites W1971280577 @default.
• W978756987 cites W1971419826 @default.
• W978756987 cites W1972031185 @default.
• W978756987 cites W1975186771 @default.
• W978756987 cites W1984704484 @default.
• W978756987 cites W1989057702 @default.
• W978756987 cites W2009504559 @default.
• W978756987 cites W2013051826 @default.
• W978756987 cites W2014357452 @default.
• W978756987 cites W2017196865 @default.
• W978756987 cites W2026826794 @default.
• W978756987 cites W2032699876 @default.
• W978756987 cites W2033024008 @default.
• W978756987 cites W2041150576 @default.
• W978756987 cites W2043216151 @default.
• W978756987 cites W2048151760 @default.
• W978756987 cites W2051529579 @default.
• W978756987 cites W2054138958 @default.
• W978756987 cites W2067131989 @default.
• W978756987 cites W2074425311 @default.
• W978756987 cites W2079279014 @default.
• W978756987 cites W2083611552 @default.
• W978756987 cites W2088095316 @default.
• W978756987 cites W2112867689 @default.
• W978756987 cites W2114564015 @default.
• W978756987 cites W2117746945 @default.
• W978756987 cites W2118693086 @default.
• W978756987 cites W2124433362 @default.
• W978756987 cites W2141034604 @default.
• W978756987 cites W2142097265 @default.
• W978756987 cites W2144395887 @default.
• W978756987 cites W2147862518 @default.
• W978756987 cites W2148047805 @default.
• W978756987 cites W2148841241 @default.
• W978756987 cites W2150579113 @default.
• W978756987 cites W2151367307 @default.
• W978756987 cites W2154047650 @default.
• W978756987 cites W2158872718 @default.
• W978756987 cites W2162309072 @default.
• W978756987 cites W2264044367 @default.
• W978756987 cites W2315152253 @default.
• W978756987 cites W2323604865 @default.
• W978756987 cites W2525887285 @default.
• W978756987 cites W2590425307 @default.
• W978756987 cites W2916599355 @default.
• W978756987 cites W47262818 @default.
• W978756987 cites W99162695 @default.
• W978756987 doi "https://doi.org/10.1371/journal.pone.0132620" @default.
• W978756987 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4510363" @default.
• W978756987 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26197471" @default.
• W978756987 hasPublicationYear "2015" @default.
• W978756987 type Work @default.
• W978756987 sameAs 978756987 @default.
• W978756987 citedByCount "13" @default.
• W978756987 countsByYear W9787569872016 @default.
• W978756987 countsByYear W9787569872017 @default.
• W978756987 countsByYear W9787569872018 @default.
• W978756987 countsByYear W9787569872020 @default.
• W978756987 countsByYear W9787569872021 @default.
• W978756987 countsByYear W9787569872022 @default.
• W978756987 countsByYear W9787569872023 @default.
• W978756987 crossrefType "journal-article" @default.
• W978756987 hasAuthorship W978756987A5000815865 @default.
• W978756987 hasAuthorship W978756987A5001717980 @default.
• W978756987 hasAuthorship W978756987A5012278873 @default.

• next